Pallavicini M G, Redfearn W, Necas E, Brecher G
Cancer Center, University of California, San Francisco, CA 94143, USA.
Blood Cells Mol Dis. 1997 Aug;23(2):157-68. doi: 10.1006/bcmd.1997.0133.
Repopulation by donor cells of a bone marrow ablated by irradiation is now recognized to proceed in two phases: initial repopulation that may be temporary followed by permanent engraftment of longterm repopulating cells (LTRC). While a single LTRC has been shown to be capable of restoring the entire lymph-hemopoietic system of an irradiated animal, the identity of the temporary repopulating cells has not been established unequivocally. We used the results of transplantation of subpopulations successively enriched for LTRC and containing varying numbers of CFU-S-12 (colony-forming units in the spleen at day 12 post transplantation) and progenitors to determine the likely cell type and number of cells needed for initial survival after radiation. Subpopulations from untreated and 5-fluorouracil-treated mice were discriminated on the basis of antibody reactivity, Hoechst 33342 and rhodamine 123 fluorescence intensity and light scattering properties. The minimum rescue inocula varied greatly in CFU-GEMM, BFU-E and CFU-GM content. One to two CFU-S-12 were uniformly present in all isolated suspensions that rescued 50% of lethally irradiated animals. In view of the known average seeding efficiency of CFU-S, our studies suggest that transfusion of 10-20 CFU-S day 12/13 is responsible for radioprotection. Evidence that multiple CFU-S day 12/13 are needed for initial repopulation is also supported by quantitative estimates of the number of mature cells that can be produced by CFU-S. Transfusion of a single CFU-S day 12/13 can be shown to be grossly inadequate to provide the number of peripheral blood cells needed to ameliorate the severe pancytopenia following lethal irradiation by day 12-14. Our data also indicate that 5-fluorouracil-treated marrow subpopulations appear inferior to untreated subpopulations in their ability to contribute to initial repopulation when transfused at low cell doses into lethally irradiated recipients.
现在已经认识到,受照射后被消融的骨髓由供体细胞重新填充的过程分为两个阶段:初始重新填充可能是暂时的,随后是长期重新填充细胞(LTRC)的永久植入。虽然已证明单个LTRC能够恢复受照射动物的整个淋巴造血系统,但暂时重新填充细胞的身份尚未明确确定。我们利用连续富集LTRC并含有不同数量的CFU-S-12(移植后第12天脾脏中的集落形成单位)和祖细胞的亚群移植结果,来确定辐射后初始存活所需的可能细胞类型和细胞数量。根据抗体反应性、Hoechst 33342和罗丹明123荧光强度以及光散射特性,区分来自未处理和5-氟尿嘧啶处理小鼠的亚群。CFU-GEMM、BFU-E和CFU-GM含量的最小挽救接种物差异很大。在所有挽救了50%致死性照射动物的分离悬液中,均一致存在1至2个CFU-S-12。鉴于已知CFU-S的平均接种效率,我们的研究表明,在第12/13天输注10 - 20个CFU-S可起到辐射防护作用。CFU-S可产生的成熟细胞数量的定量估计也支持了初始重新填充需要多个第12/13天的CFU-S这一证据。在第12/13天输注单个CFU-S明显不足以提供在第12 - 14天缓解致死性照射后严重全血细胞减少所需的外周血细胞数量。我们的数据还表明,当以低细胞剂量输注到致死性照射的受体中时,5-氟尿嘧啶处理的骨髓亚群在促进初始重新填充的能力方面似乎不如未处理的亚群。